CN Patent

CN115260211B — 含噻吩稠环类衍生物、药物组合物及其制备方法和应用

Assigned to Changchun Genescience Pharmaceutical Co Ltd · Expires 2024-02-06 · 2y expired

What this patent protects

本发明提供了一种式(I)所示的噻吩稠环类衍生物、药物组合物及其制备方法和应用。该化合物具有良好的GnRH受体拮抗作用，可用于治疗或预防与性腺激素有关的病症和疾病，以及制备用于此类病症和疾病的药物。

USPTO Abstract

本发明提供了一种式(I)所示的噻吩稠环类衍生物、药物组合物及其制备方法和应用。该化合物具有良好的GnRH受体拮抗作用，可用于治疗或预防与性腺激素有关的病症和疾病，以及制备用于此类病症和疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN115260211B
Jurisdiction
CN
Classification
—
Expires
2024-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Changchun Genescience Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.